可吸收止血材料的生物相容性研究进展

doi:10.3969/j.issn.0258-8021. 2016.02.016

摘要
图/表
参考文献
相关文章 (7)

全文: PDF (768 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要可吸收止血材料是指用于伤口止血的可在体内降解吸收的生物医用材料，目前其在手术中止血发挥着重要作用。国内外近年来主要使用的可吸收止血材料包括壳聚糖、纤维蛋白原、α-氰基丙烯酸酯、氧化纤维素和胶原蛋白等，除止血效果外，其生物相容性正成为评价止血材料优劣的重要指标。在生物相容性的安全性和功能性原则指导下，对比它们在实验中的生物相容性结果，综合评价各类可吸收止血材料的生物相容性，为进一步研发良好生物相容性的可吸收止血材料以及日后的使用提供参考意见。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	邓乐君¹
	3樊鸿浩¹
	3李伟达¹
	2朱晋辉³李茹冰¹
	3*

关键词 ：可吸收止血材料, 生物相容性, 安全性

Abstract：Absorbable hemostatic materials are one of biomedical materials that applied to stanch bleeding. They are degradable in vivo and play an important role in the surgical hemostasis. In recent years, absorbable haemostatic materials mainly include chitosan, fibrinogen, cyanoacrylates, oxidized cellulose, collagen. Except for hemostatic effect, the biocompatibility is also an important feature for the quality of these materials. In this article, we made a comprehensive evaluation among the absorbable hemostatic materials under the guidance of safety and efficacy of biocompatibility, aiming to provide a valuable reference for the utility and development of absorbable hemostatic materials in further research.

Key words： absorbable haemostatic materials biocompatibility safety

基金资助:广东省产学研专项（2012B091100170）；广东省科技计划项目（广东省重大科技专项）（2012A080204010）；广州市科技计划项目（201509010012）；重大新药创制（2013ZX09J13110）

引用本文:

邓乐君^1,3樊鸿浩^1,3李伟达^1，2朱晋辉³李茹冰^1，3*. 可吸收止血材料的生物相容性研究进展[J]. 中国生物医学工程学报, 2016, 35(2): 241-246.
Deng Lejun^1,3Fan Honghao^1,3Li Weida^1，2Zhu Jinhui³ Li Rubing^1，3*. Progress in the Study on Biocompatibility of Absorbable Hemostatic Materials. journal1, 2016, 35(2): 241-246.

链接本文:

http://cjbme.csbme.org/CN/10.3969/j.issn.0258-8021. 2016.02.016 或 http://cjbme.csbme.org/CN/Y2016/V35/I2/241

［1］杨晓芳，奚廷斐.生物材料生物相容性评价研究进展［J］.生物医学工程学杂志，2001,18（1）：123-128.
［2］张世庆，赵雄，鲁景艳，等.可吸收止血材料研究现状与相关技术要求［J］.军事医学，2012,36（11）：862-866.
［3］Gu BK, Park SJ, Kim MS, et al. Gelatin blending and sonication of chitosan nanofiber mats produce synergistic effects on hemostatic functions［J］. Int J Biol Macromol, 6 Oct,2015［Epub ahead of print］.
［4］宋来福，邵凯，刘万顺，等.壳聚糖即型水凝胶的理化性质、止血功能和生物相容性研究［J］.功能材料，2014,45（9）：9065-9069.
［5］李若慧，张雪，单丹彤，等.壳聚糖的生物相容性［J］.中国组织工程研究，2012,16（12）：2237-2240.
［6］孟晓荣，王琼，赵亮，等. 壳聚糖/PHB/PEG多元共混膜的制备与体外血液相容性研究［J］.功能材料，2010,
41（12）：2198-2202.
［7］郭苗苗，浦金辉，徐丹，等.壳聚糖基快速止血材料的研究进展［J］.中国医院药学杂志，2012,32（1）：49-51.
［8］Zhang Zhe, Cui Huifei. Biodegradability and biocompatibility study of poly (Chitosanglactic Acid) scaffolds［J］.Molecules,2012,17(3):3243-3258.
［9］田昆仑，刘良明，范小青，等.异丁基壳聚糖多功能创面敷料的生物学效应［J］.中国临床康复，2005, 9（38）：33-35.
［10］姜毅，王风华，段蕴铀. 多糖类止血材料的研究及应用进展［J］.解放军医学杂志，2014,39（12）：1004-1007.
［11］马茂，范代娣.壳聚糖-类人胶原蛋白对兔肝创面的止血效果及组织相容性观察［J］.第四军医大学学报，2007,28（12）：1122-1124.
［12］Alfars A, Khashjoori BK.Evaluation of effectiveness of chitosan hydrogel as haemostatic from dorsal nasal veins in rabbits［J］. Bas J Vet Res,2008,7（1）:19-25.
［13］Wang Xiaohong, Yan Yongnian, Zhang Renji. A comparison of chitosan and collagen sponges as hemostatic dressings［J］.Journal of Bioactive and Compatible Polymers，2006，21(1): 39-54.
［14］薛燕.组织粘合剂在伤口中的应用［J］.中国医疗器械信息，2012,18（2）：7-12.
［15］Lins RDAU, Gomes RCB, Santos KSM, et al. Use of cyanoacrylate in the coaptation of edges of surgical wounds［J］. An Bras Dermatol, 2012,87(6):871-876.
［16］Toriumi DM, Baqal AA. Cyanoacrylate tissue adhesives for skin closure in the outpatient setting［J］.Otolarynqol Clin North Am, 2002,35(1):103-18.
［17］Montanaro L, Arciola CR, Cenni E. Cytotoxicity, blood compatibility and antimicrobial activity of two cyanoacrylate glues for surgical use［J］. Biomaterials, 2001,22(1):59-66.［18］Barreno AC, Vergiú CC, Malatto JR. Biocompatibility of nbutylcyanoacrylate compared to conventional skin sutures in skin wounds［J］. Revista Odontológica Mexicana, 2013, 17 (2): 81-89.
［19］Lee YJ, Jung GB, Cho SJ, et al. Biocompatibility of a novel cyanoacrylate based tissue adhesive: cytotoxicity and biochemical property evaluation［J］.PLoS ONE,2013,8(11):1-9.
［20］蔡大振，徐亮，孟庆国，等. α\|氰基丙烯酸酯类医用黏合剂的研究进展［J］.军事医学，2012,36（3）：238-241.
［21］Bae KB, Kim SH, Jung SJ, et al. Cyanoacrylate for colonic anastomosis: is it safe?［J］. Int J Colorect Dis,2010,
25(5)：601-606.
［22］宋强，肖世维，但年华，等.胶原在止血材料中的应用［J］.西部皮革，2013,35（4）：8-14.
［23］Farndale RW, Sixma JJ, Barnes MJ, Groot PG. The role of collagen in thrombosis and hemostasis［J］.Thrombosis and Haemostasis, 2004, 2:561-573.
［24］刘新华，但年华，李正军，等.胶原基复合医用海绵的研究进展［J］.西部皮革，2012,34（8）：13-17. 
［25］Parenteau\|Bareil R, Gauvin R, Berthod F.CollagenBased biomaterials for tissue engineering applications ［J］.Material,2010,3:1863-1887.
［26］Soo C, Trahbar G, Moy RL. The immunogenicity of bovine collagen implants［J］. I Dermatol Surg Oncol, 1993,
19(5):431- 434.
［27］冯玉萍，马忠仁，乔自林.新生牛跟腱胶原蛋白海绵与细胞的生物相容性［J］.中国组织工程研究与临床康复，2007,11（1）：70-73.
［28］迟妍妍，乐尧金，刘旭超，等. 胶原蛋白海绵的生物特性及体内降解吸收［J］.中国组织工程研究，2014,18（34）：5515-5519.
［29］Duan Zhiguang，Fan Daidi，Zhu Chenhui. Hemostatic efficacy of humanlike collagen sponge in arterioles and liver injury model［J］. African Journal of Microbiology Research, 2012,6(10): 2543-2551.
［30］Hermans MHE, Brown L, Darmoc M. Adhesion prevention in an intraperitoneal wound model: Performance of two resorbable hemostats in a controlled study in rabbits［J］. J Biomed Mater Res B Appl Biomater, 2012, 100(6): 1621-1626.
［31］Antonio F, Guillem R, Sonia T, et al. Cross\|linked collagen sponges loaded with plant polyphenols with inhibitory activity towards chronic wound enzymes［J］. Biotechnol J, 2011, 6(10): 1208-1218.
［32］Kim YW, Kang MJ, Lee HJ,et al. The efficacy of TachoComb on reducing postoperative complications after tonsillectomy in children［J］. Int J Pediatr Otorhinolaryngol, 2015,79(8):1337-1340.
［33］Ramasamy P, Shanmugam A. Characterization and wound healing property of collagenchitosan film from Sepia kobiensis (Hoyle, 1885)［J］. Int J of Biol Macromol, 2015, 74: 93-102
［34］Li B, Liu X, Cao C, et al. Biocompatibility and antibacterial activity of plasma sprayed titania coating grafting collagen and gentamicin［J］. J Biomed Mater Res, 2007, 83〖STBZ〗(4): 923-930.
［35］Matthews J A, Wnek G E, Simpson D G, et al. Electrospinning of collagen nanofibers［J］. Biomacromolecules, 2002, 3(2): 232-238.
［36］Dickneite G, Metzner HJ, Kroez M, et al. The importance of factor Ⅷ as a component of fibrin sealants［J］. J Surg Res, 2002,107（2）：186-195.
［37］Kram HB, Hino ST, Harley DP, et al. Use of concentrated fibrinogen in experimental splenic trauma［J］. J Biomed Mater Res, 1986 20(5):547-553.
［38］Kjaergard H.K., Axelsen P. Effectiveness of autologous fibrin sealant in experimental lung surgery［J］. Eur Surg Res, 1996,28(2):162-166.
［39］苏怡，候延文，高珉之.医用生物蛋白胶生物性能的研究［J］.预防医学情报杂志，2001,17（6）：433-435.
［40］王春仁，王召旭，宋谊萍，等.医用纤维蛋白胶亚急性毒性实验研究［J］.中国药事，2007,21（7）：472-474.
［41］蔡阳，任真，何学军，等.纤维蛋白黏合剂免疫原性的研究［J］.免疫学杂志，2011,27（9）：769-772.
［42］Nichols W. Adverse antibodymediated reactions to topical bovine thrombin and fibrin glue［C］ // Nichols W Symposium on Fibrin Sealant: Characteristics and Clinical Use. Bethesda: Uniformed Services University of the Health Sciences, 1994: 5-10. 
［43］TomizawaY. Clinical benefits and risk an alysis of topical hemostats:a review［J］.J Artif Organs,2005,8(3):137
［44］王丽，相秉仁，邹巧根.氧化纤维素的制备及结构和性能的研究［J］.药学进展2009,33(8):365-369.
［45］Kakaei F, Seyyed Sadeghi MS, Sanei B, et al. A randomized clinical trial comparing the effect of different haemostatic agents for haemostasis of the liver after hepatic resection［J］. HPB Surgery, 2013, 2013:1-5.
［46］Ibrahim MF, Aps C, Young CP.A foreign body reaction to Surgicel mimicking an abscess following cardiac surgery［J］. Eur J Cardiothorac Surg，2002，22(3):489\|490．
［47］李明洋，黄赤兵，范明齐，等.负压吸附式止血敷贴的制备及生物相容性［J］.中国组织工程研究与临床康复，2011,15（47）:8813-8816.
［48］姜丽娟，李玲，张春霞，等.可吸收多糖微球的制备及生物相容性研究［J］.生物医学工程研究，2014,33〖STBZ〗（1）：32-34.
［49］Nunamaker E A, Purcell E K, Kipke D R. In vivo stability and biocompatibility of implanted calcium alginate disks［J］. J Biomed Mater Res A, 2007, 83(4): 1128-1137.
［50］Lai J Y. Biocompatibility of chemically crosslinked gelatin hydrogels for ophthalmic use［J］. J Mater Sci Med, 2010, 21(6): 1899-1911.